Development of an Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment Based on Multimodal Data Fusion Using Deep Learning Technology

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

To improve the accuracy of risk prediction, screening and treatment outcome of cancer, we aim to establish a medical database that includes standardized and structured clinical diagnosis and treatment information, image features, pathological features, and multi-omics information and to develop a multi-modal data fusion-based technology system using artificial intelligence technology based on database.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: t
View:

• Participants with the suspected of lung cancer/node, or stomach cancer/lesion, or colorectal cancer/leision

• Participants that have signed informed consent.

• Participants with detailed electronic medical records, image records, pathological records, multi-omics information, and other important clinical diagnostic information.

• Healthy participants with no clinical diagnosis of lung cancer/node, or stomach cancer/lesion, or colorectal cancer/leision.

Locations
Other Locations
China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITING
Wuhan
Contact Information
Primary
Yang Jin
whuhjy@126.com
15107177084
Time Frame
Start Date: 2022-06-01
Estimated Completion Date: 2026-10
Participants
Target number of participants: 3000
Treatments
Lung cancer group
Participants with lung cancer/pulmonary nodules
Stomach cancer group
Participants with Stomach cancer/Stomach lesion
Colorectal cancer group
Participants with Colorectal cancer/Colorectal lesion
Sponsors
Leads: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

This content was sourced from clinicaltrials.gov